ISOPP 2023 Symposium – Call for Abstracts

ISOPP 2023 Abstract submission is open! Submit your abstract(s) online by Thursday, October 13, 2022. View submission information and guidelines on the ISOPP 2023 website, and read below this message for more information about the Symposium (abstract submission, key dates, venue and more).

Review the resource on how to write an abstract for tips on how to write an abstract for a scientific meeting. A useful tool guiding you in the process of preparing a well-written abstract, especially if it is your first time!

ISOPP 2023 takes place March 2 to 4, 2023, followed by one day Masterclasses on March 5, at the Barceló Sevilla Renacimiento in Seville, Spain. The national hosts are El Grupo Español Para El Desarrollo de la Farmacia Oncológica (GEDEFO) and Sociedad Espanola de Farmacia Hospitalaria (SEFH).

Visit the ISOPP 2023 website for more information and Symposium updates as they are made available. Spread the word using #ISOPP2023 and please forward this notice to your friends and colleagues who may be interested in what the Symposium has to offer and encourage them to join ISOPP’s mailing list.

We look forward to receiving your abstracts and seeing you in Seville in March 2023!

Yours sincerely

 

Evelyn Handel

ISOPP President

 

Estela Moreno

ISOPP 2023 Symposium Chair and

Scientific Program Co-chair

Latest News

By BOPA Committee on 3rd May 2025

Let’s Talk About SACT podcast has been featured in the TOP 40 pharmacology Podcasts worldwide

The BOPA podcast team (Michal Sladkowski, Chiara Creed and Eleanor Meerstadt) are thrilled to share that the Let’s Talk About SACT podcast has been featured in the TOP 40 pharmacology…

Read article
By BOPA Education & Training Subcommittee on 3rd May 2025

NEW eLearning module for Myeloma now live

Dear BOPA members,   The Education and Training subcommittee are pleased to announce that our new e-learning module for myeloma is now live on the BOPA website. The module can…

Read article
By BOPA Research Committee on 27th April 2025

SURVEY: Understanding Clinicians’ perceptions of a Decision Support tool for Lung Cancer Treatment

Dear BOPA member, Tarini Deleep and Dr Pinkie Chambers from University College London are developing a risk prediction model to help identify patients with incurable Non Small Cell Lung Cancer,…

Read article
By BOPA on 27th April 2025

Further monographs for use of immunosuppressants in Immune-related adverse events (irAEs)

Earlier this year the BOPA Immunotherapy Group wrote, and published, four monographs to help health care professionals care for patients with immune-related adverse events. As a group we are pleased…

Read article